Oxford, UK – Today, OGT announced the launch of a new next-generation sequencing (NGS) panel for Measurable Residual Disease (MRD) – the SureSeq™ Myeloid MRD Plus NGS Panel. Designed using OGT’s 30 years of expertise in hybrid capture technology, the panel detects ultra-low frequency variants in key MRD-associated biomarkers in acute myeloid leukaemia (AML). This means users […]

QIAsymphony Connect, the next generation of automated nucleic acid purification platform, to be shown at AMP 2025 as early access phase begins ahead of full release in mid-2026 QIAGEN showcases Sample to Insight workflows for comprehensive genomic profiling (CGP) based on Element Biosciences Trinity™ technology Partnership with Myriad Genetics Inc. to highlight development of a […]

Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins Broadens Amperia’s applications across recombinant protein research, screening, and development Abselion to showcase kit alongside Amperia platform at PEGS Europe in Lisbon, Portugal from 11–13 November Cambridge, UK: Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has […]

Redefining Scalability, Automation, and Clinical Yield in Genomic Interpretation BOZEMAN, Mont. — Golden Helix, Inc. announced the release of VarSeq 3 and VSWarehouse 3, the company’s next-generation platform for secondary and tertiary genomic analysis. Building on more than a decade of trusted innovation, the clinical utility of VarSeq 3 has been expanded through industry partnerships and customer collaborations. […]

Funding will accelerate commercialization of its breakthrough biomarker detection platform MUSE®. Oberkochen, Germany | ZEISS Group ZEISS Ventures participated in an oversubscribed financing round of CHF 6.3 million for arcoris bio, a Swiss start-up specializing in a platform technology aimed at enhancing biomolecule detection and imaging for spatial multiomics solutions. The funding round, co-led by […]

Integrates Alithea Genomics’ MERCURIUS FLASH-seq single-cell RNA-seq protocol with SPT Labtech’s firefly liquid handling platform Enables higher-throughput, cost efficient single-cell sequencing Cambridge, UK, and Lausanne, Switzerland — SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and Alithea Genomics, a pioneer in the field of large-scale RNA sequencing […]

NanoTemper Strengthens Biopharma Discovery Portfolio with Acquisition of Envue Technologies and Launch of Dianthus™ α NanoTemper’s two strategic milestones – NSM technology acquisition and the launch of Dianthus™ α application – expand its capabilities across the life sciences value chain and enhance support for the discovery of next-generation therapeutics. The Envue Technologies acquisition brings Nanofluidic Scattering […]

CAMBRIDGE, England — Novogene Europe is pleased to announce the launch of its new Whole Plasmid Sequencing service, powered by Oxford Nanopore Technologies (ONT). This service offering represents a major step forward in plasmid verification, providing researchers with a powerful and practical alternative to traditional Sanger sequencing. Unlike conventional approaches, whole plasmid sequencing delivers a […]

– TAPS+ enables simultaneous detection of methylation and genetic variants, unlocking new insights for precision oncology and translational research. – Preserves DNA integrity in challenging clinically relevant samples, including FFPE tissue and circulating tumor DNA (ctDNA). – Platform-agnostic chemistry enables seamless integration across sequencing systems. BOULDER, Colo. — Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology […]

LONDON, UK — Touchlight, a leader in cell-free DNA technology, today announced the expansion of its groundbreaking mbDNA™ platform with the introduction of three new circular DNA architectures: sscDNA, hsscDNA, and dscDNA. These innovative constructs join mbDNA, which debuted earlier this year, to form a comprehensive portfolio designed to overcome the limitations of traditional gene editing tools. […]